We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+15.45%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$201B
AUM Growth
+$18.3B
Cap. Flow
-$13B
Cap. Flow %
-6.47%
Top 10 Hldgs %
24.23%
Holding
10,449
New
1,429
Increased
3,737
Reduced
3,810
Closed
1,252

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$415M
2
LLY icon
Eli Lilly
LLY
+$402M
3
GS icon
Goldman Sachs
GS
+$384M
4
MCD icon
McDonald's
MCD
+$379M
5
TSLA icon
Tesla
TSLA
+$304M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.98B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$596M
3
T icon
AT&T
T
+$460M
4
SYF icon
Synchrony
SYF
+$398M
5
HON icon
Honeywell
HON
+$342M

Sector Composition

Rank Sector Weight
1 Technology 5.97%
2 Financials 4.82%
3 Healthcare 4.18%
4 Industrials 3.64%
5 Consumer Discretionary 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GASS icon
8601
StealthGas
GASS
$351M
$56K ﹤0.01%
+16,032
New +$51.3K
KWY
8602
Kingsway Corp
KWY
$284M
$56K ﹤0.01%
+18,075
New +$43.1K
AIOS
8603
AIOS Tech
AIOS
$39.2M
$56K ﹤0.01%
296
+169
+133% +$30.1K
OCSL icon
8604
PUT
Oaktree Specialty Lending
OCSL
$1.15B
$56K ﹤0.01%
3,600
-133
-4% -$1.98K
MARK
8605
CALL
DELISTED
Remark Holdings, Inc.
MARK
$56K ﹤0.01%
3,020
-1,760
-37% -$35.8K
FRTX
8606
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$56K ﹤0.01%
149
+63
+73% +$21.1K
AGEN
8607
Agenus
AGEN
$332M
$55K ﹤0.01%
940
-7,994
-89% -$496K
ALTO icon
8608
PUT
Alto Ingredients
ALTO
$325M
$55K ﹤0.01%
56,200
+40,000
+247% +$47K
ASRT
8609
PUT
DELISTED
Assertio
ASRT
$55K ﹤0.01%
182
-305
-63% -$78.7K
WKHS icon
8610
Workhorse Group
WKHS
$32.4M
$55K ﹤0.01%
30
+12
+67% +$31.4K
ACHV icon
8611
Achieve Life Sciences
ACHV
$769M
$54K ﹤0.01%
+831
New +$33.6K
FET icon
8612
PUT
Forum Energy Technologies
FET
$968M
$54K ﹤0.01%
+530
New +$58.3K
ONCY
8613
Oncolytics Biotech
ONCY
$101M
$54K ﹤0.01%
+29,520
New +$59.8K
RETO icon
8614
ReTo Eco-Solutions
RETO
$10.8M
0
UAN icon
8615
CVR Partners
UAN
$1.3B
$54K ﹤0.01%
1,376
-748
-35% -$28.5K
CLUB
8616
CALL
DELISTED
Town Sports International Holdings, Inc.
CLUB
$54K ﹤0.01%
+11,400
New +$65K
CORV
8617
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$54K ﹤0.01%
17,214
+2,015
+13% +$6.52K
NL icon
8618
NLI Holdings
NL
$315M
$53K ﹤0.01%
13,590
-958
-7% -$3.92K
PRPH
8619
DELISTED
ProPhase Labs
PRPH
$53K ﹤0.01%
+1,759
New +$54.2K
SUP
8620
PUT
DELISTED
Superior Industries International
SUP
$53K ﹤0.01%
11,100
-11,900
-52% -$63.7K
CSCI
8621
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$53K ﹤0.01%
+113
New +$43.9K
ATHX
8622
CALL
DELISTED
Athersys, Inc. Common Stock
ATHX
$53K ﹤0.01%
1,424
-344
-19% -$13.2K
MLNT
8623
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$53K ﹤0.01%
14,790
-363
-2% -$1.97K
IBRX icon
8624
ImmunityBio
IBRX
$7.95B
$52K ﹤0.01%
32,671
+5,618
+21% +$7.05K
STKL
8625
CALL
DELISTED
SunOpta
STKL
$52K ﹤0.01%
14,900
-11,700
-44% -$45.3K

Similar funds

Ken Griffin's Q1 2019 Portfolio in Review

As of Q1 2019, Ken Griffin held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin withdrew a net $13B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 4.8% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in Elanco Animal Health worth $251M.

  • Ken Griffin's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
  • Ken Griffin added most to Walt Disney in Q1 2019, an estimated $415M increase.
  • Ken Griffin's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
  • Ken Griffin fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
  • Ken Griffin's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
  • Ken Griffin opened 1,429 new positions and closed 1,252 in Q1 2019.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $201B.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.